Your browser doesn't support javascript.
loading
Requirement for epithelial p38α in KRAS-driven lung tumor progression.
Vitos-Faleato, Jessica; Real, Sebastián M; Gutierrez-Prat, Nuria; Villanueva, Alberto; Llonch, Elisabet; Drosten, Matthias; Barbacid, Mariano; Nebreda, Angel R.
Afiliação
  • Vitos-Faleato J; Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Real SM; Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Gutierrez-Prat N; Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Villanueva A; Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research, 08907 L'Hospitalet de Llobregat, Spain.
  • Llonch E; Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Drosten M; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, 28029 Madrid, Spain.
  • Barbacid M; Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, 28029 Madrid, Spain.
  • Nebreda AR; Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; angel.nebreda@irbbarcelona.org.
Proc Natl Acad Sci U S A ; 117(5): 2588-2596, 2020 02 04.
Article em En | MEDLINE | ID: mdl-31969449
ABSTRACT
Malignant transformation entails important changes in the control of cell proliferation through the rewiring of selected signaling pathways. Cancer cells then become very dependent on the proper function of those pathways, and their inhibition offers therapeutic opportunities. Here we identify the stress kinase p38α as a nononcogenic signaling molecule that enables the progression of KrasG12V-driven lung cancer. We demonstrate in vivo that, despite acting as a tumor suppressor in healthy alveolar progenitor cells, p38α contributes to the proliferation and malignization of lung cancer epithelial cells. We show that high expression levels of p38α correlate with poor survival in lung adenocarcinoma patients, and that genetic or chemical inhibition of p38α halts tumor growth in lung cancer mouse models. Moreover, we reveal a lung cancer epithelial cell-autonomous function for p38α promoting the expression of TIMP-1, which in turn stimulates cell proliferation in an autocrine manner. Altogether, our results suggest that epithelial p38α promotes KrasG12V-driven lung cancer progression via maintenance of cellular self-growth stimulatory signals.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Proteína Quinase 14 Ativada por Mitógeno / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Proteína Quinase 14 Ativada por Mitógeno / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha